Literature DB >> 2062769

Parkinson and his disease revisited.

D G James1, R Hierons.   

Abstract

Entities:  

Mesh:

Year:  1991        PMID: 2062769      PMCID: PMC2399015          DOI: 10.1136/pgmj.67.785.227

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  9 in total

1.  Surgical occlusion of the anterior choroidal artery in parkinsonism.

Authors:  I S COOPER
Journal:  Surg Gynecol Obstet       Date:  1954-08

2.  Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease.

Authors:  O Lindvall; P Brundin; H Widner; S Rehncrona; B Gustavii; R Frackowiak; K L Leenders; G Sawle; J C Rothwell; C D Marsden
Journal:  Science       Date:  1990-02-02       Impact factor: 47.728

Review 3.  Parkinson's disease.

Authors:  C D Marsden
Journal:  Lancet       Date:  1990-04-21       Impact factor: 79.321

Review 4.  Rational management of the 'on-off' syndrome in Parkinson's disease.

Authors:  R J Coleman
Journal:  Q J Med       Date:  1990-02

5.  L-Dopa for Parkinsonism.

Authors:  G C Cotzias
Journal:  N Engl J Med       Date:  1968-03-14       Impact factor: 91.245

6.  Amantadine in the treatment of Parkinson's disease.

Authors:  R S Schwab; A C England; D C Poskanzer; R R Young
Journal:  JAMA       Date:  1969-05-19       Impact factor: 56.272

7.  The effect of deprenyl (selegiline) on the natural history of Parkinson's disease.

Authors:  J W Tetrud; J W Langston
Journal:  Science       Date:  1989-08-04       Impact factor: 47.728

8.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.

Authors:  J W Langston; P Ballard; J W Tetrud; I Irwin
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

9.  Long-term treatment of parkinsonism with bromocriptine.

Authors:  D B Calne; C Plotkin; A C Williams; J G Nutt; A Neophytides; P F Teychenne
Journal:  Lancet       Date:  1978-04-08       Impact factor: 79.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.